The invitation from GSK's general manager struck everyone like a thunderclap.
"Wu Ting actually published a special feature in Cell!"
"He actually received an invitation to collaborate with GSK for a starting salary of two million pounds! That's insane!"
"What did he do to deserve that? This is GSK we're talking about!"
The students and faculty in attendance were utterly stunned. It was only then that they realized this grand lecture had been organized specifically for Wu Ting and a potential collaboration on his project!
Many had heard of Wu Ting's "One-Yuan Project" before, but at the time, they had all dismissed it with a laugh, paying it no mind. Now, it turned out his project had already yielded such incredible results.
"A negative immunomodulatory mechanism that could potentially revolutionize the entire diagnostic and treatment system for HBV-related primary liver cancer!"
Yan Xi and Wang Nanjin stared wide-eyed at Wu Ting in the front row. 'He's really this brilliant?'
